发明名称 |
Containers for compositions comprising meloxicam |
摘要 |
A plastic container containing a pharmaceutical composition comprising benzoic acid or a derivative or a pharmaceutically acceptable salt thereof and a COX-inhibitor of the oxicam-type or a pharmaceutical acceptable salt thereof, wherein the container material selected from one or more members of the group consisting of a homopolymer of polypropylene (PP), a copolymer of polypropylene (PP), a homopolymer of polyethylene terephthalate (PET) and a copolymer of polyethylene terephthalate (PET), and optionally one or more non-polymeric components. |
申请公布号 |
US9186296(B2) |
申请公布日期 |
2015.11.17 |
申请号 |
US201313799901 |
申请日期 |
2013.03.13 |
申请人 |
Boehringer Ingelheim Vetmedica GmbH |
发明人 |
Folger Martin A.;Crowley Samuel C.;Wilson Amy J. |
分类号 |
B65D81/00;B65D81/02;B65D83/40;A61J1/00;A61J1/05;A61J1/14;A61K47/12;A61J1/20 |
主分类号 |
B65D81/00 |
代理机构 |
|
代理人 |
Morris Michael P.;Morrison Joyce L. |
主权项 |
1. A pharmaceutically acceptable container containing a pharmaceutical composition including sodium benzoate, the container being formed of a container material selected from one or more members of the group constisting of a homopolymer of polypropylene (PP), a copolymer of polypropylene (PP), a homopolymer of polyethylene terephthalate (PET) and a copolymer of polyethylene terephthalate (PET);
wherein the container material does not include high-density polyethylene (HDPE), low-densisty polyethylene (LDPE), or polycarbonate (PC); and a loss in concentration (mg/mL) of sodium benzoate in said pharmaceutical composition due to adsorption onto said container when stored for a period of 6 months at 25° C. and a relative humidity of 60% is no more than 5%. |
地址 |
Ingelheim am Rhein DE |